NGGT has initiated Phase I/II clinical trials in the U.S. and China to evaluate the safety and efficacy of NGGT002 for the <a ta ...

Obesity, alcohol use and other factors are driving up rates of fatty liver disease among American adults, new research warns. By 2018, federal data showed that 42% of adults had some form of fatty ...

“With our initial 40-week span of positive results, we are optimistic that our Phase I/II clinical trials will further elucidate NGGT002’s potential to treat this rare and debilitating disease in a ...

The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy ...

Q3 2024 Earnings Call Transcript November 7, 2024 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.39, ...

NEW YORK, Nov. 11 (UPI) --Deaths from cardiovascular disease have surged among adults ages 25 to 64 living in rural areas, a new study shows. The study is to be presented Sunday at the American ...

GENEVA, SWITZARLAND / ACCESSWIRE / October 29, 2024 /RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering ...

Fifth disease, also known as erythema infectiosum, is a contagious viral illness caused by parvovirus B19. It is most common in children, but it can also affect adults. The main symptom of fifth ...

Get detailed information on Pegvaliase-pqpz, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated ...

Treatment for severe RSV in adults ensures the patient can breathe, drink, and eat adequately and safely. These treatments can include: The Food and Drug Administration (FDA) has approved three ...